Home › Funds › Englebert Financial Advisers, LLC › JNJ

Englebert Financial Advisers, LLC position in JNJ

JOHNSON & JOHNSON · Health Care

Englebert Financial Advisers, LLC reported holding 5,387 shares of JNJ (JOHNSON & JOHNSON) in its Q3 2026 13F filing — a position valued at US$1.4M, representing 1.46% of its reported portfolio and ranking #12 among its reported holdings. Englebert Financial Advisers, LLC has disclosed JNJ holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)5.39K sh
Reported value held$1.43M
Portfolio Weight1.46%
First reportedQ4 2025
Last changeReduce
Updated2026-10-21

Last updated: 2026-10-21 · Source: SEC EDGAR Form 13F-HR

How Englebert Financial Advisers, LLC's JNJ position evolved

Englebert Financial Advisers, LLC first disclosed a stake in JNJ in Q4 2025 at 5,278 shares (US$1.1M). The position peaked in Q3 2026 at 5,387 shares, worth US$1.4M. Across 4 filings, Englebert Financial Advisers, LLC increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 5,387 shares valued at US$1.4M — a reduction of -91 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q4 2025 5.28K $1.09M New
Q1 2026 5.29K $1.29M Hold
Q2 2026 5.48K $1.39M Add
Q3 2026 5.39K $1.43M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 33 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$39.93B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has Englebert Financial Advisers, LLC held JNJ?

Englebert Financial Advisers, LLC has disclosed JNJ holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is Englebert Financial Advisers, LLC's current position in JNJ?

As of Q3 2026, Englebert Financial Advisers, LLC holds 5.39K shares of JNJ (JOHNSON & JOHNSON), valued at $1.43M, representing 1.46% of its reported portfolio and ranking #12.

Has Englebert Financial Advisers, LLC been buying or selling JNJ?

In the latest 13F filing (Q3 2026), Englebert Financial Advisers, LLC reduced its position in JNJ. The position peaked in Q3 2026 at 5.39K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.